TRBUŠEK, Martin, Soňa ČEJKOVÁ, Ludmila ROČŇOVÁ, David POTĚŠIL, Jana ŠMARDOVÁ, Jitka MALČÍKOVÁ, Dita ŽEŽULKOVÁ, Michael DOUBEK, Yvona BRYCHTOVÁ, Šárka POSPÍŠILOVÁ and Jiří MAYER. Presence of heterozygous ATM deletion may not be critical for the response of CLL cells to fludarabine. In Haematologica/The hematology journal. 2008. ISSN 0390-6078.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Presence of heterozygous ATM deletion may not be critical for the response of CLL cells to fludarabine
Name in Czech Přítomnost heterozygotní delece ATM nedeterminuje odpověď CLL buněk na fludarabin
Name (in English) Presence of heterozygous ATM deletion may not be critical for the response of CLL cells to fludarabine
Authors TRBUŠEK, Martin, Soňa ČEJKOVÁ, Ludmila ROČŇOVÁ, David POTĚŠIL, Jana ŠMARDOVÁ, Jitka MALČÍKOVÁ, Dita ŽEŽULKOVÁ, Michael DOUBEK, Yvona BRYCHTOVÁ, Šárka POSPÍŠILOVÁ and Jiří MAYER.
Edition Haematologica/The hematology journal. 2008.
Other information
Type of outcome Conference abstract
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.978
Organization unit Faculty of Medicine
ISSN 0390-6078
UT WoS 000263430200541
Keywords in English CLL, ATM deletion, fludarabine, p53
Tags International impact, Reviewed
Changed by Changed by: RNDr. Ludmila Šebejová, Ph.D., učo 85269. Changed: 22/7/2010 12:08.
Links
NR8445, research and development projectName: In vitro sensitivita/resistence CLL buněk s inaktivovaným p53 na moderní léčbu
PrintDisplayed: 2/5/2024 07:38